The Technology Strategy Board and the Welsh Government are to invest up to £8m in single-company and collaborative R&D projects to support the UK’s burgeoning regenerative medicine and cell therapy industry.

The aim is to help advance the industry by addressing sector-specific challenges related to preparing novel treatments for use.

This competition will focus on the preclinical testing, clinical development and manufacture of regenerative medicines and cell therapies, and the development of associated underpinning tools and technologies.

Proposals must be business-led, and can be collaborative or single-company. The expectation is to fund industrial research projects, with a business partner attracting up to 50% public funding for their eligible project costs (60% for SMEs). Projects are expected to last between one and three years, and total project costs to range in size from £500k to £2.5m, although projects outside this range will be considered.

This is a two-stage competition that opens for applicants on 2 June 2014. The deadline for expressions of interest is at noon on 16 July 2014.

A briefing event and webinar for potential applicants will be held in London on 10 June 2014.

 

For further details please see the TSB website.